-- 
Bioline RX, Mizrahi, Partner, Protalix: Israeli Equity Preview

-- B y   C a l e v   B e n - D a v i d   a n d   R o n i t   G o o d m a n
-- 
2011-02-27T07:25:09Z

-- http://www.bloomberg.com/news/2011-02-27/bioline-rx-mizrahi-partner-protalix-israeli-equity-preview.html
The following stocks may rise or
fall in Israeli markets. Stock symbols are in parentheses after
the company names and prices are from the close unless otherwise
stated.  The TA-25 Index declined 1.8 percent to 1,272.62 in  Tel
Aviv .    Ampal-American Israel  Corp. (AMPL IT): The flow of gas from
Egypt may be delayed a few days, TheMarker business daily
reported, citing an Israeli government evaluation. The holding
company that imports the fuel earlier said it expected
resumption by the end of February. Ampal-American dropped 2.9
percent to 7.066 shekels.    Bioline RX Ltd . (BLRX IT): The biopharmaceutical company
said a trial to test the safety and effectiveness of BL-1040 in
post heart-attack patients will start in the second half.
Bioline declined 1.3 percent to 2.724 shekels.  Partner Communications Co. (PTNR IT): The country’s second-
largest mobile phone company was raised to “market perform”
from “underperform” at Meitav Investment House Ltd. Partner
fell 1.7 percent to 66.87 shekels.    Protalix BioTherapeutics Inc . (PLX IT): The biotechnology
company failed to win U.S. approval of a plant-based medicine
it’s developing with Pfizer Inc. to treat Gaucher disease.
Protalix gained 3.4 percent to 36.20 shekels.    Space Communication Ltd . (SCC IT): The supplier of
satellite communications services said it plans to offer Series
Yud-Aleph bonds under a shelf registration originally filed in
February 2010. Space Communication slipped 0.2 percent to 69.86
shekels.  To contact the reporters on this story:
Calev Ben-David in Jerusalem at 
 cbendavid@bloomberg.net ;
Ronit Goodman in Tel Aviv at 
 rgoodman9@bloomberg.net   To contact the editor responsible for this story:
Claudia Maedler at 
 cmaedler@bloomberg.net  